A 100% human milk-based fortifier from Prolacta® Bioscience
A New Option for Human Milk-Based Nutrition
First fortifier indicated for use in term infants.
Research. Recovery. Results.
Achieving adequate growth and weight gain is critical for healthy development in critically ill infants requiring a corrective surgical procedure. Developed by Prolacta Bioscience®, Surgifort® is the first and only 100% human milk-based fortifier intended for term infants with gastroschisis who have undergone a corrective procedure.
Nutritional benefits, as part of an EHMD
As a human milk–based, human milk fortifier, Surgifort is designed to meet the nutritional needs of full-term infants undergoing corrective surgery for gastroschisis. An Exclusive Human Milk Diet (EHMD) is achieved when 100% of protein, fat, and carbohydrate are derived from human milk; This diet includes a human milk–based fortifier. When used as part of an EHMD, and added to mother’s own milk or to donor human milk, Surgifort fortifier provides an appropriate amount of calories, protein, and minerals† required for infants to grow and heal. The ability to concentrate Surgifort fortifier ensures that nutritional needs can be met even when fluids are restricted.
Nutrition is an important detail
As part of Prolacta dedication to improving outcomes for critically ill infants, for over twenty years, Prolacta’s human milk-based nutritional products have helped adequately feed premature infants all over the world. When used as part of an EHMD in clinical studies, Prolacta human milk-based fortifiers for preterm infants have been shown to:
Now we’re bringing the power of human milk to critically ill term infants with gastroschisis, requiring corrective surgical procedure. For more information about Surgifort® fortifier or the Exclusive Human Milk Diet (EHMD), please contact your Prolacta representative.